S&P 500   3,435.56 (-0.22%)
DOW   28,210.82 (-0.35%)
QQQ   284.19 (-0.08%)
AAPL   116.87 (-0.54%)
MSFT   214.80 (+0.07%)
FB   278.73 (+4.17%)
GOOGL   1,585.99 (+2.25%)
AMZN   3,184.94 (-1.00%)
TSLA   422.64 (+0.17%)
NVDA   540.99 (-0.88%)
BABA   307.97 (-0.59%)
CGC   19.49 (+3.23%)
GE   7.32 (-0.27%)
MU   53.31 (-0.41%)
AMD   79.20 (-2.89%)
T   26.72 (-0.15%)
F   7.85 (+1.42%)
ACB   4.85 (+6.36%)
GILD   60.21 (-0.56%)
NFLX   489.05 (-6.92%)
BA   163.86 (-2.02%)
BAC   24.05 (-0.37%)
NIO   27.86 (-0.36%)
S&P 500   3,435.56 (-0.22%)
DOW   28,210.82 (-0.35%)
QQQ   284.19 (-0.08%)
AAPL   116.87 (-0.54%)
MSFT   214.80 (+0.07%)
FB   278.73 (+4.17%)
GOOGL   1,585.99 (+2.25%)
AMZN   3,184.94 (-1.00%)
TSLA   422.64 (+0.17%)
NVDA   540.99 (-0.88%)
BABA   307.97 (-0.59%)
CGC   19.49 (+3.23%)
GE   7.32 (-0.27%)
MU   53.31 (-0.41%)
AMD   79.20 (-2.89%)
T   26.72 (-0.15%)
F   7.85 (+1.42%)
ACB   4.85 (+6.36%)
GILD   60.21 (-0.56%)
NFLX   489.05 (-6.92%)
BA   163.86 (-2.02%)
BAC   24.05 (-0.37%)
NIO   27.86 (-0.36%)
S&P 500   3,435.56 (-0.22%)
DOW   28,210.82 (-0.35%)
QQQ   284.19 (-0.08%)
AAPL   116.87 (-0.54%)
MSFT   214.80 (+0.07%)
FB   278.73 (+4.17%)
GOOGL   1,585.99 (+2.25%)
AMZN   3,184.94 (-1.00%)
TSLA   422.64 (+0.17%)
NVDA   540.99 (-0.88%)
BABA   307.97 (-0.59%)
CGC   19.49 (+3.23%)
GE   7.32 (-0.27%)
MU   53.31 (-0.41%)
AMD   79.20 (-2.89%)
T   26.72 (-0.15%)
F   7.85 (+1.42%)
ACB   4.85 (+6.36%)
GILD   60.21 (-0.56%)
NFLX   489.05 (-6.92%)
BA   163.86 (-2.02%)
BAC   24.05 (-0.37%)
NIO   27.86 (-0.36%)
S&P 500   3,435.56 (-0.22%)
DOW   28,210.82 (-0.35%)
QQQ   284.19 (-0.08%)
AAPL   116.87 (-0.54%)
MSFT   214.80 (+0.07%)
FB   278.73 (+4.17%)
GOOGL   1,585.99 (+2.25%)
AMZN   3,184.94 (-1.00%)
TSLA   422.64 (+0.17%)
NVDA   540.99 (-0.88%)
BABA   307.97 (-0.59%)
CGC   19.49 (+3.23%)
GE   7.32 (-0.27%)
MU   53.31 (-0.41%)
AMD   79.20 (-2.89%)
T   26.72 (-0.15%)
F   7.85 (+1.42%)
ACB   4.85 (+6.36%)
GILD   60.21 (-0.56%)
NFLX   489.05 (-6.92%)
BA   163.86 (-2.02%)
BAC   24.05 (-0.37%)
NIO   27.86 (-0.36%)
Log in
NYSEAMERICAN:INFU

InfuSystem Stock Forecast, Price & News

$13.20
-0.14 (-1.05 %)
(As of 10/21/2020 04:15 PM ET)
Add
Compare
Today's Range
$13.06
Now: $13.20
$13.50
50-Day Range N/A
52-Week Range
$5.26
Now: $13.20
$15.19
Volume32,947 shs
Average Volume108,673 shs
Market Capitalization$266.61 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210
Employees237

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$266.61 million
Next Earnings Date11/11/2020 (Estimated)
OptionableNot Optionable
$13.20
-0.14 (-1.05 %)
(As of 10/21/2020 04:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of InfuSystem?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InfuSystem in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for InfuSystem
.

When is InfuSystem's next earnings date?

InfuSystem is scheduled to release its next quarterly earnings announcement on Wednesday, November 11th 2020.
View our earnings forecast for InfuSystem
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) posted its quarterly earnings data on Thursday, August, 13th. The medical instruments supplier reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.17. The medical instruments supplier earned $26 million during the quarter.
View InfuSystem's earnings history
.

What guidance has InfuSystem issued on next quarter's earnings?

InfuSystem updated its FY 2020 Pre-Market earnings guidance on Thursday, August, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $94-97 million, compared to the consensus revenue estimate of $88 million.

What price target have analysts set for INFU?

2 brokerages have issued 1-year target prices for InfuSystem's stock. Their forecasts range from $17.00 to $28.00. On average, they expect InfuSystem's share price to reach $22.50 in the next year. This suggests a possible upside of 70.5% from the stock's current price.
View analysts' price targets for InfuSystem
.

Are investors shorting InfuSystem?

InfuSystem saw a decline in short interest in the month of September. As of September 30th, there was short interest totaling 263,000 shares, a decline of 17.4% from the September 15th total of 318,500 shares. Based on an average daily volume of 109,400 shares, the short-interest ratio is currently 2.4 days. Approximately 1.5% of the company's shares are sold short.
View InfuSystem's Short Interest
.

Who are some of InfuSystem's key competitors?

What other stocks do shareholders of InfuSystem own?

Who are InfuSystem's key executives?

InfuSystem's management team includes the following people:
  • Mr. Richard A. DiIorio, Pres, CEO & Director (Age 44)
  • Mr. Gregory Schulte, Exec. VP & CFO (Age 52)
  • Mr. Thomas Mark Ruiz, Sr. VP of Sales & Marketing
  • Mr. John Haggerty, Sr. VP of Biomedical Services & Logistics
  • Ms. Jean Pfeiffer, Sr. VP of Strategic Initiatives

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by a number of institutional and retail investors. Top institutional investors include Wedge Capital Management L L P NC (0.53%). Company insiders that own InfuSystem stock include Awm Investment Company, Inc, Barry G Steele, Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Meridian Ohc Partners, Lp, Paul Andrew Gendron, Richard Dilorio, Scott Shuda and Thomas Mark Ruiz.
View institutional ownership trends for InfuSystem
.

Which major investors are buying InfuSystem stock?

INFU stock was acquired by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC. Company insiders that have bought InfuSystem stock in the last two years include Awm Investment Company, Inc, Barry G Steele, Carrie Lachance, Christopher R Sansone, Jeannine Sheehan, Paul Andrew Gendron, Richard Dilorio, and Scott Shuda.
View insider buying and selling activity for InfuSystem
.

How do I buy shares of InfuSystem?

Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $13.20.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $266.61 million. InfuSystem employs 237 workers across the globe.

What is InfuSystem's official website?

The official website for InfuSystem is ir.infusystem.com.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.

This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.